Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome- |
RCV001554520 | SCV001775774 | benign | Developmental and epileptic encephalopathy, 42 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554521 | SCV001775775 | benign | Episodic ataxia type 2 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554522 | SCV001775776 | benign | Migraine, familial hemiplegic, 1 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001554523 | SCV001775777 | benign | Spinocerebellar ataxia type 6 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001685523 | SCV001897163 | benign | not provided | 2019-08-10 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV004594358 | SCV005087279 | benign | not specified | 2024-07-15 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 94% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 87. Only high quality variants are reported. |